References
- Case D B, Atlas S A, Laragh J H, Sealey J E, Sullivan P A, McKinstry D N. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor(SQ 14 225, captopril) in hypertensive patients. Progress in Cardiovascular Disease. 1978; 21: 195–206
- Linger T, Bühler I K, Schölkens B, Ganten D. Brain converting enzyme inhibition, a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1981; 70: 467–478
- Castellucci A, Bacciarelli C, Boni C, Fedi M. The rat mesenteric artery-intestinal loop preparation. Arzneim Forsch Drug Res. 1981; 31: 54–58
- Tsuda K, Kuchii M, Nishio I, Masuyama Y. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats. Clin Exp Hypertens. 1986; 8: 259–275
- Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detector. Life Sci. 1979; 25: 131–138
- Clough D P, Collis M G, Hatton R, Keddie J R. Effect of angiotensin converting enzyme inhibitor on neurogenic vasoconstriction in the rat. Blood Vessels. 1980; 17: 147
- Antonaccio M J, Kerwin L. Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats. Eur J Pharmacol. 1980; 68: 209–212
- Re R, Fallon J T, Dzau V, Quay S C, Harber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci. 1982; 30: 99–106
- Toda N, Miyazaki M, Okamura T. Vascular neuroeffector function in two-kidney, one clip hypertensive dogs. J Hypertension. 1985; 3: 503–509
- Garst J, Koletsky S, Wisenbaugh P E, Haddy M, Matthews D. Arterial wall renin and renal venous renin in the hypertensive rat. Clin Sci. 1979; 56: 41–46